Autoimmune diseases in which IBD and SLE manifest have aberrations in CB2 signaling associated with the maintenance of inflammation, while the crass over-activation of CB1 in the periphery leads to the development of obesity, insulin resistance, and Type II Diabetes Mellitus [236,237]. This evidence concerns the gene CNR2 and irritable bowel syndrome.